. 2022; 39(3): 204-205 | DOI: 10.4274/tjh.galenos.2022.2022.0247  

Kronik Myeloid Lösemi Tedavisine Yanıt Tahmininde Başlangıç BCR: : ABL1 Düşüş Hızı

Susan Branford
Centre for Cancer Biology, SA Pathology, Adelaide, Australia; University of South Australia, School of Pharmacy and Medical Science, Adelaide, Australia; University of Adelaide, School of Medicine, Adelaide, Australia



Initial Rate of BCR: : ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia

Susan Branford
Centre for Cancer Biology, SA Pathology, Adelaide, Australia; University of South Australia, School of Pharmacy and Medical Science, Adelaide, Australia; University of Adelaide, School of Medicine, Adelaide, Australia



Susan Branford. Initial Rate of BCR: : ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia. . 2022; 39(3): 204-205

Sorumlu Yazar: Susan Branford, Australia


ARAÇLAR
Tam Metin PDF
Yazdır
Alıntıyı İndir
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
E-Postala
Paylaş
Yazara e-posta gönder

Benzer makaleler
Google Scholar